Silgan Unicep

Executive Summary

Silgan Unicep is a premier contract manufacturer specializing in the mixing, filling, and packaging of unit-dose liquids, gels, and creams. Founded in 1991, the company operates FDA-registered, ISO 13485:2016-certified facilities and offers end-to-end services from formulation assistance to secondary packaging. Serving diverse markets including diagnostics, animal health, oral healthcare, and consumer healthcare, Silgan Unicep has established itself as a trusted partner for both emerging and established brands. The company's focus on unit-dose formats positions it well in a market increasingly driven by convenience, precision, and patient compliance. With its private ownership and niche expertise, Silgan Unicep is poised to benefit from the growing demand for contract manufacturing in drug delivery, particularly in areas such as ophthalmic, injectable, and topical applications. The company's long-standing reputation and regulatory compliance provide a competitive edge amid a trend toward outsourcing by pharmaceutical and consumer health companies.

Upcoming Catalysts (preview)

• Q3 2026Major new contract with a top pharmaceutical company for unit-dose ophthalmic or injectable products70% success
• Q4 2026Expansion into cannabis or CBD unit-dose market through facility upgrades or strategic partnership60% success
• Q2 2026Completion of a new high-speed filling line to increase capacity for high-demand products80% success